Cesar de Almeida Neto
University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cesar de Almeida Neto.
Revista Do Instituto De Medicina Tropical De Sao Paulo | 2001
Cesar de Almeida Neto; Edna Strauss; Esther Cerdeira Sabino; Maria Cecília Araripe Sucupira; Dalton de Alencar Fischer Chamone
The clinical significance of isolated anti-HBc is still a challenge. To elucidate the real importance of this finding in our blood donors, an investigation algorithm was tested. One hundred and twelve isolated anti-HBc seropositive blood donors underwent clinical evaluation and retesting of HBV markers. Those who presented repeatedly reactive isolated anti-HBc, received a single dose of hepatitis B recombinant vaccine to verify anti-HBs early response. A HBV-DNA determination by PCR was done for those who did not test positive to anti-HBs after vaccine. The level of anti-HBc was recorded as a ratio of the sample-to-cut-off values (S:C ratio) in 57 candidates at donation. Comparing true and false-positive anti-HBc results, the different S:C ratios of them were statistically significant and when less than 2, implying in a false-positive result probability over 80%. A high percent of false-positive results (16.07%) was verified after anti-HBc retesting. HBV immunity was characterized in 49.11%, either by anti-HBs detection in retesting (15.18%), or after a single dose HBV vaccination (33.93%). HBV-DNA was negative in all tested donors. In conclusion, this algorithm was useful to clarify the meaning of isolated anti-HBc in most of our blood donors.
Transfusion | 2007
Cesar de Almeida Neto; William McFarland; Edward L. Murphy; Sanny Chen; Fátima Aparecida Hangai Nogueira; Alfredo Mendrone; Nanci A. Salles; Dalton de Alencar Fischer Chamone; Ester C. Sabino
BACKGROUND: The objective of this study was to investigate risk factors of human immunodeficiency virus (HIV)‐seropositive blood donors in Brazil and to determine if current donor deferral criteria are appropriate.
Transfusion | 2009
Alfredo Mendrone; Ester C. Sabino; Luciana Ribeiro Sampaio; Cesar de Almeida Neto; George B. Schreiber; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer
BACKGROUND: Anemia screening before blood donation requires an accurate, quick, practical, and easy method with minimal discomfort for the donors. The aim of this study was to compare the accuracy of two quantitative methods of anemia screening: the HemoCue 201+ (Aktiebolaget Leo Diagnostics) hemoglobin (Hb) and microhematocrit (micro‐Hct) tests.
Transfusion | 2009
Cesar de Almeida Neto; Edward L. Murphy; William McFarland; Alfredo Mendrone Júnior; Sanny Chen; Dalton de Alencar Fischer Chamone; Ester C. Sabino
BACKGROUND: Syphilis screening of blood donors is a common practice worldwide, but very little is known about the meaning of a positive serologic test for syphilis in blood donors and the risk profile of these donors. The aim of this study was to determine the demographic characteristics and risk behaviors of blood donors with recent and past syphilis and their implications for blood bank testing and deferral strategies.
Liver International | 2004
Mario Antonio Torezan‐Filho; Venancio Avancini Ferreira Alves; Cesar de Almeida Neto; Helena Sabino Fernandes; Edna Strauss
Abstract: Alanine aminotransferase (ALT) elevation in blood donors can be related to many variables such as viral hepatitis, overweight and ethanol consumption.
Transfusion | 2012
Cesar de Almeida Neto; Alfredo Mendrone; Brian Custer; Jing Liu; Anna Bárbara Carneiro-Proietti; Silvana Leão; David Wright; Edward L. Murphy; Ester C. Sabino
BACKGROUND: In Brazil, most donations come from repeat donors, but there are little data on return behavior of donors.
Transfusion and Apheresis Science | 2009
Alfredo Mendrone; Cyntia Araujo Arrais; Cesar de Almeida Neto; Sandra F.M. Gualandro; Pedro Enrique Dorlhiac-Llacer; Dalton de Alencar Fischer Chamone; Ester C. Sabino
One limiting factor for automated two-red blood cells collections (2-RBC) is its potential iron depletion. We analyzed hematological parameters and iron balance before, two and four months after 2-RBC of 96 non-supplemented male donors. Four months after 2-RBC, ferritin level was significantly lower (P<0.01) than baseline levels and the number of donors who presented ferritin <30 ng/ml increased from 18 to 47. We concluded that four months was not sufficient for iron recuperation in the population studied. In an attempt to avoid iron depletion after 2-RBC, we recommend augmentation in the interval between blood donations and pre-donation ferritin measurement.
Revista Brasileira De Hematologia E Hemoterapia | 2014
Cesar de Almeida Neto
See paper by Braz AC et al. on pages 139-146. *Corresponding author at: Serviço de Hemoterapia Nove de Julho, Rua Peixoto Gomide, 613, Cerqueira César, 01409-902, São Paulo, SP, Brazil. E-mail address: [email protected] (C. A. Neto). 1516-8484/
Revista Brasileira De Hematologia E Hemoterapia | 2011
Cesar de Almeida Neto
see front matter
Revista Brasileira De Hematologia E Hemoterapia | 2008
Cesar de Almeida Neto; Mirianceli C. Mendonça; Marcelo C. Braga; Fabiana S. Ghaname; Fernanda O. S. Gobette; Verônica S. P. Pires; Anis Ganme; Jorge N. Ghaname
by physicians. Yet personal experience points to a common oversight; the failure to escalate doses to pre-set targets, within the bounds of tolerance. Incomplete compliance with oral anti-neoplastic therapy by patients/families is common and multifactorial, and reported truthfully and accurately by them.(9) Non-compliance is especially challenging in adolescents.(9) Improvement can be achieved simply, effectively and inexpensively by behavioral strategies such as self-monitoring, contracting and reinforcement programs.(10) It is no less important to minimize poor adherence to protocols by physicians. The putative survival advantage enjoyed by patients on clinical trials has been attributed, in large measure, to good adherence. Improving physician performance in this domain can be accomplished by continuous monitoring, an exercise to which nurses and clinical pharmacists can make considerable contributions, and by formal audits. Such improvements have been shown to increase survival.(11) Dr. Oliveira and colleagues are to be complimented on drawing attention to an area of clinical practice all-too-often overlooked. They are encouraged to remedy the deficiencies that they have uncovered and report on the anticipated benefits at a later date.